Vasocure is a clinical-stage vascular therapeutics company with the world’s first peptide to directly treat neointimal disease and atherosclerosis.
Company Details
- Founded
- -
- Address
- New York City, Ny 10012, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- New York City, NY
Vasocure Questions
Vasocure's website is https://www.vasocuretherapeutics.com
Vasocure's LinkedIn profile is https://www.linkedin.com/company/vasocure
Vasocure's industry is
Pharmaceutical Manufacturing
Vasocure's top competitors are
Dub Therapeutics,
Retrn Bio,
Genkardia,
Libama Power Corporation,
Mechanismic Inc,
Nomis Power,
Copprium,
Azimuth Biologics, Inc,
Cyberspara Inc,
Qas.ai.
Vasocure's categories are Pharmaceutical Manufacturing
Vasocure's founding year is 2018
